T1DM-patients (n = 88) | Controls (n = 60) | p-value* | |
---|---|---|---|
Age (years) | 61.3 ± 7.1 | 62.3 ± 6.8 | 0.38 |
Female, n% | 47 (53.4) | 34 (56.7) | 0.70 |
Body mass index (kg/m3) | 25.8 ± 3.9 | 25.5 ± 4.2 | 0.69 |
Waist circumference (cm) | 90.3 ± 13.2 | 89.1 ± 12.2 | 0.55 |
Previous CVD, n% | 6 (6.8) | 2 (3.3) | 0.36 |
Angina, typical | 2 (2.3) | 0 (0.0) | 0.49 |
Angina, atypical | 21 (24.1) | 14 (23.3) | |
No angina | 64 (73.6) | 46 (76.7) | |
Systolic blood pressure (mmHg) | 146 ± 19.8 | 137 ± 19.3 | < 0.01 |
wSystolic blood pressure (mmHg) | 130 ± 10.6 | ||
Diastolic blood pressure (mmHg) | 75.3 ± 8.4 | 81.7 ± 9.7 | < 0.01 |
Pulse pressure | 71.6 ± 16.1 | 55.0 ± 14.1 | < 0.01 |
Heart rate (bpm) | 68 ± 10.3 | 62 ± 9.3 | < 0.01 |
Hypertensiona, n% | 23 (26.4) | 11 (18.3) | 0.25 |
Hyperlipidemiab, n% | 27 (31.0) | 12 (20.0) | 0.17 |
Family history of CVD, n% | 10 (11.5) | 13 (21.7) | 0.05 |
Daily smokers, n% | 5 (5.7) | 6 (10) | 0.62 |
Ex-smokers, n% | 34 (38.6) | 22 (36.7) | |
pro-BNP (ng/L) | 104.9 ± 110.1 | 67.4 ± 51.3 | < 0.01 |
eGFR | 85 ± 19.2 | 82 ± 12.8 | 0.18 |
Statin use, n% | 40 (45.5) | 6 (10.0) | < 0.01 |
HDL-c (mmol/L) | 2.1 ± 0.5 | 1.8 ± 0.5 | < 0.01 |
Statin years | 2.8 ± 4.3 | ||
LDL-c (mmol/L) | 2.8 ± 0.8 | 3.9 ± 1.0 | < 0.01 |
wLDL-c (mmol/L) | 2.9 ± 0.6 | ||
Triglycerides (mmol/L), median (IQR) | 0.77 (0.39–2.85) | 0.93 (0.52–2.96) | < 0.01 |
HbA1c (mmol/mol) | 7.4 ± 0.81 | 5.4 ± 0.28 | < 0.01 |
wHbA1c (mmol/mol) | 7.9 ± 0.83 |